368 related articles for article (PubMed ID: 22247936)
1. Characterization of bupivacaine-loaded formulations based on liquid crystalline phases and microemulsions: the effect of lipid composition.
Yaghmur A; Rappolt M; Østergaard J; Larsen C; Larsen SW
Langmuir; 2012 Feb; 28(5):2881-9. PubMed ID: 22247936
[TBL] [Abstract][Full Text] [Related]
2. Self-assembled multicompartment liquid crystalline lipid carriers for protein, peptide, and nucleic acid drug delivery.
Angelova A; Angelov B; Mutafchieva R; Lesieur S; Couvreur P
Acc Chem Res; 2011 Feb; 44(2):147-56. PubMed ID: 21189042
[TBL] [Abstract][Full Text] [Related]
3. Evaluating the link between self-assembled mesophase structure and drug release.
Phan S; Fong WK; Kirby N; Hanley T; Boyd BJ
Int J Pharm; 2011 Dec; 421(1):176-82. PubMed ID: 21963475
[TBL] [Abstract][Full Text] [Related]
4. SAXS investigation of a cubic to a sponge (L3) phase transition in self-assembled lipid nanocarriers.
Angelov B; Angelova A; Mutafchieva R; Lesieur S; Vainio U; Garamus VM; Jensen GV; Pedersen JS
Phys Chem Chem Phys; 2011 Feb; 13(8):3073-81. PubMed ID: 21079857
[TBL] [Abstract][Full Text] [Related]
5. Citrem-phosphatidylcholine nano-self-assemblies: solubilization of bupivacaine and its role in triggering a colloidal transition from vesicles to cubosomes and hexosomes.
Prajapati R; Larsen SW; Yaghmur A
Phys Chem Chem Phys; 2019 Jul; 21(27):15142-15150. PubMed ID: 31243413
[TBL] [Abstract][Full Text] [Related]
6. In situ monitoring of the formation of lipidic non-lamellar liquid crystalline depot formulations in synovial fluid.
Yaghmur A; Rappolt M; Jonassen ALU; Schmitt M; Larsen SW
J Colloid Interface Sci; 2021 Jan; 582(Pt B):773-781. PubMed ID: 32916575
[TBL] [Abstract][Full Text] [Related]
7. In situ phase transition of microemulsions for parenteral injection yielding lyotropic liquid crystalline carriers of the antitumor drug bufalin.
Li Y; Angelova A; Liu J; Garamus VM; Li N; Drechsler M; Gong Y; Zou A
Colloids Surf B Biointerfaces; 2019 Jan; 173():217-225. PubMed ID: 30296646
[TBL] [Abstract][Full Text] [Related]
8. Spatially and time-resolved SAXS for monitoring dynamic structural transitions during in situ generation of non-lamellar liquid crystalline phases in biologically relevant media.
Mertz N; Yaghmur A; Østergaard J; Amenitsch H; Larsen SW
J Colloid Interface Sci; 2021 Nov; 602():415-425. PubMed ID: 34144300
[TBL] [Abstract][Full Text] [Related]
9. Structure formation and characterization of injectable drug loaded biodegradable devices: in situ implants versus in situ microparticles.
Kranz H; Bodmeier R
Eur J Pharm Sci; 2008 Jul; 34(2-3):164-72. PubMed ID: 18501569
[TBL] [Abstract][Full Text] [Related]
10. Lyotropic, liquid crystalline nanostructures of aqueous dilutions of SMEDDS revealed by small-angle X-ray scattering: impact on solubility and drug release.
Goddeeris C; Goderis B; Van den Mooter G
Eur J Pharm Sci; 2010 May; 40(2):110-7. PubMed ID: 20298780
[TBL] [Abstract][Full Text] [Related]
11. Influence of the stabilizer concentration on the internal liquid crystalline order and the size of oil-loaded monolinolein-based dispersions.
Guillot S; Salentinig S; Chemelli A; Sagalowicz L; Leser ME; Glatter O
Langmuir; 2010 May; 26(9):6222-9. PubMed ID: 20143786
[TBL] [Abstract][Full Text] [Related]
12. Injectable in situ forming gel based on lyotropic liquid crystal for persistent postoperative analgesia.
Mei L; Xie Y; Huang Y; Wang B; Chen J; Quan G; Pan X; Liu H; Wang L; Liu X; Wu C
Acta Biomater; 2018 Feb; 67():99-110. PubMed ID: 29225151
[TBL] [Abstract][Full Text] [Related]
13. Investigation of diclofenac release and dynamic structural behavior of non-lamellar liquid crystal formulations during in situ formation by UV-Vis imaging and SAXS.
Mertz N; Bock F; Østergaard J; Yaghmur A; Weng Larsen S
Int J Pharm; 2022 Jul; 623():121880. PubMed ID: 35661744
[TBL] [Abstract][Full Text] [Related]
14. Interaction between lamellar (vesicles) and nonlamellar lipid liquid-crystalline nanoparticles as studied by time-resolved small-angle X-ray diffraction.
Vandoolaeghe P; Barauskas J; Johnsson M; Tiberg F; Nylander T
Langmuir; 2009 Apr; 25(7):3999-4008. PubMed ID: 19714888
[TBL] [Abstract][Full Text] [Related]
15. Emulsified microemulsions and oil-containing liquid crystalline phases.
Yaghmur A; de Campo L; Sagalowicz L; Leser ME; Glatter O
Langmuir; 2005 Jan; 21(2):569-77. PubMed ID: 15641825
[TBL] [Abstract][Full Text] [Related]
16. Characterization of oil-free and oil-loaded liquid-crystalline particles stabilized by negatively charged stabilizer citrem.
Nilsson C; Edwards K; Eriksson J; Larsen SW; Østergaard J; Larsen C; Urtti A; Yaghmur A
Langmuir; 2012 Aug; 28(32):11755-66. PubMed ID: 22831645
[TBL] [Abstract][Full Text] [Related]
17. Phytantriol-based inverted type bicontinuous cubic phase for vascular embolization and drug sustained release.
Han K; Pan X; Chen M; Wang R; Xu Y; Feng M; Li G; Huang M; Wu C
Eur J Pharm Sci; 2010 Dec; 41(5):692-9. PubMed ID: 20883779
[TBL] [Abstract][Full Text] [Related]
18. Revisiting β-casein as a stabilizer for lipid liquid crystalline nanostructured particles.
Zhai J; Waddington L; Wooster TJ; Aguilar MI; Boyd BJ
Langmuir; 2011 Dec; 27(24):14757-66. PubMed ID: 22026367
[TBL] [Abstract][Full Text] [Related]
19. Real time evolution of liquid crystalline nanostructure during the digestion of formulation lipids using synchrotron small-angle X-ray scattering.
Warren DB; Anby MU; Hawley A; Boyd BJ
Langmuir; 2011 Aug; 27(15):9528-34. PubMed ID: 21678977
[TBL] [Abstract][Full Text] [Related]
20. Structural characterization of lipidic systems under nonequilibrium conditions.
Yaghmur A; Rappolt M
Eur Biophys J; 2012 Oct; 41(10):831-40. PubMed ID: 22569535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
